Evaluation of Relationship Between Hypersexuality and Psychostimulant Among Men Who Have Sex With Men

Hospices Civils de Lyon55 enrolled

Overview

Survey of fifty new psychoactive substances consumers in a context of MTM sexual intercourse. Evaluation using an hetero-assessment questionnaire about the link between hypersexual disorder and the use of synthetic cathinone. Evaluation on psychoactive drug addiction, the induced or pre-existing sexual practices and the medico-psycho-social consequences of those practices.

Study Type

OBSERVATIONAL

Enrollment

Conditions

Psychoactive Substances Consumers

Interventions

G-STAT questionnaireOTHER

Patients will have a consultation with an addiction specialist physician. During the consultation, the physician ask the patient about these sexual practice and the use of psychostimulants. The patient will answer to the G-STAT questionnaire. This questionnaire allows the physician to perform an initial assessment of the patient's sexual addiction. The entire consultation takes place in the usual practice of consultations for this addiction.

Eligibility

Sex: MALEMin age: 18 Years

Medical Language ↔ Plain English

* Inclusion Criteria: * Patients ≥ 18 years * Male homosexual and / or bisexual who come to the CSAPA at the Croix-Rousse Hospital, Lyon France following the use of psychostimulants products in sexual contexts * Patients who have received clear information and not opposed to participate in the study * Patients affiliated to a social security scheme or similar * Patients not undergoing a measure of legal protection * Exclusion Criteria: * Opposition to participation in the study * Patients \< 18 years * Pregnant women or breastfeeding * Deprived of individual liberty

Locations (1)

Hospices Civils de Lyon

Lyon, France

Outcomes

Primary Outcomes

G-STAT questionnaire

Determine whether there are elements sexual addiction or if its elements are induced by the specific use of psychostimulants. The determination will be made using the interrogation conducted during the CSAPA consultation and G-STAT questionnaire.

Time frame: Day 0

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.